Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy

Neuromuscular Disorders

Volumn 7, Issue 3, 1997, Pages 191-197

  Ishii, Hiroko ^a,b   Hayashi, Yukiko K ^a   Nonaka, Ikuya ^c   Arahata, Kiichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Tokyo Metropolitan Higashiyamato Medical Center for the Severe Disabled   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Basal lamina; Electron microscopy; Fukuyama congenital muscular dystrophy

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MUSCLE CELL; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; SKELETAL MUSCLE;

BASEMENT MEMBRANE; CHILD, PRESCHOOL; COLLAGEN; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; DYSTROPHIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LAMININ; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; SARCOGLYCANS;

EID: 0030982138     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00462-8     Document Type: Article

References (46)

1. Dubowitz V. Muscular dystrophies. In: Dubowitz V, editor. Muscle Disorders in Childhood. London, UK: WB Saunders, 1995:34-133.
2. Wallon J, Gardner-Medwin D. The muscular dystrophies. In: Wallon J, editor. Disorders of Voluntary Muscle. 5th edn. Edinburgh: Churchill Livingstone, 1988:519-87.
3. Nonaka I, Chou SM. Congenital muscular dyslrophy. In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Amsterdam: North-Holland, 1979:27-50.
4. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Paediatr Univ Tokyo 1960;4:5-8.
5. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210.
6. Santavuori P, Leisti J, Kraus S. Muscle, eye and brain disease: a new syndrome (abstract). Neuropaediatrie 1977;8(Suppl):553.
7. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev (Tokyo) 1989;11:147-53.
8. Tome FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sei Paris, Science de la vie/life sciences 1994;317:351-57.
9. Hillaire D, Leclerc A, Fauré S, et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-61.
10. Hayashi YK, Koga R, Tsukahara T, et al. Deficiency of laminin alpha 2- chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 1995;18:1027-30.
11. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet 1995;11:216-18.
12. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type: clinical genetic and pathologic considerations. Brain Dev (Tokyo) 1981;13:1-29.
13. Kamoshita S, Konishi Y, Segawa M, Fukuyama Y. Congenital muscular dystrophy as a disease of the central nervous system. Arch Neurol 1976;33:513-6.
14. Takeshita K, Yoshino K, Kitahara T, Nakashima T, Kalo N. Survey of Duchenne type and congenital type of muscular dystrophy in Shimane, Japan. Jpn J Hum Genet (Tokyo) 1977;22:43-7.
15. Takada K, Nakamura H, Tanaka J. Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). J Neuropathol Exp Neurol 1984;43:395-407.
16. Takada K, Nakamura H, Suzumori K, Ishikawa T, Sugiyama N. Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD). Acta Neuropathol 1987;74:300-6.
17. Nakano I, Funahashi M, Takada K, Toda T. Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? - Pathological study of the cerebral cortex of an FCMD fetus. Acta Neuropathol 1996;91:313-21.
18. Segawa M. Histological, histochemical and electron microscopical studies of biopsied muscle of congenital muscular dystrophy (arthrogrypotic type congenital muscular dystrophy with mental retardation and facial muscle involvement). No to Hattatsu (Brain Dev/in Japanese)(Tokyo) 1971;3:21-36.
19. Nonaka I, Miyoshino S, Miike T, Ueno T, Usuku G. An electron microscopical study of the muscle in congenital muscular dystrophy. Kumamoto Med J 1972;25:68-82.
20. Misugi N. Light and electron microscopic studies of congenital muscular dystrophy. Brain Dev (Tokyo) 1980;2:191-9.
21. Nonaka I, Sugita H, Takada K, Kumagai K. Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement. Muscle Nerve 1982;5:102-6.
22. Miike T. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies. Muscle Nerve 1983;6:545-52.
23. Terasawa K. Muscle regeneration and satellite cells in Fukuyama type congenital muscular dystrophy. Muscle Nerve 1986;9:465-70.
24. Arikawa E, Ishihara T, Nonaka I, Sugita H, Arahata K. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy. J Neurol Sei 1991;105:79-87.
25. Hayashi YK, Engvall E, Arikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sei 1993; 119:53-64.
26. Toda T, Segawa M, Nomura Y, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nature Genet 1993;5:283-6.
27. Toda T, Ikegawa S, Okui K, et al. Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy: Evidence for strong linkage disequilibrium. Am J Hum Genet 1994;55: 946-50.
28. Vuolteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): Complete primary structure, chromosomal assignment. and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-94.
29. Campbell KP. Three muscular dystrophies: Loss of cytoskeletonextracellular matrix linkage. Cell 1995;80:675-9.
30. Yurchenco PD and O'Rear J. Supramolecular organization of basement membranes. In: Rohrbach DH, Timpl R, editors. Molecular and Cellular Aspects of Basement Membranes. New York: Academic Press, 1993:19-47.
31. Dubowitz V, Fardeau M. Workshop report: Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. Neuromusc Disord 1995;5:253-8.
32. Osari S, Kobayashi O, Yamashita Y, et al. Basement membrane abnormality in merosin-negative congenital muscular dystrophy. Acta Neuropathol 1996:91:332-6.
33. Arahata K, Hayashi YK, Koga R, et al. Laminin in animal models for muscular dystrophy: Defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jpn Acad 1993;69 Ser B:259-64.
34. Arahata K, Ishii H, Hayashi YK. Congenital muscular dystrophies. Curr Opin Neurol 1995:8:385-90.
35. Hayashi YK, Mizuno Y, Yoshida M, et al. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: Immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology 1995:45:551-4.
36. Arahata K, Hayashi YK, Mizuno Y, Yoshida M, Ozawa E. Dystrophin-associated glycoprotein and dystrophin co-localization at sarcolemma in Fukuyama congenital muscular dystrophy. Lancet 1993:342:623-4.
37. Woo M, Tanabe Y, Ishii H, et al. Muscle fiber growth and necrosis in dystrophic muscles: a comparative study between dy and mdx. J Neurol Sei 1987;82:111-22.
38. Nonaka I, Miike T, Ueno T, Miyoshino S. An ultrastructural observation of satellite cells in the biopsied muscle of congenital muscular dystrophy. No to Hattatsu (Brain Dev/in Japanese)(Tokyo) 1973:5: 80-9.
39. Sanes JR. The extracellular matrix. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill, 1994:242-60.
40. Hunter DD, Shah V, Merlie JP, Sanes JR. A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. Nature 1989;338:229-34.
41. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1995;4:1711-6.
42. Higuchi I. Yamada H, Fukunaga H, et al. Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. J Clin Invest 1994;94:601-6.
43. Higuchi I, Fukunaga H, Matsumura K, et al. Abnormal expression of heparan sulfate proteoglycan on basal lamina of muscle fibers in two Japanese patients with adhalin deficiency. Neuromusc Disord 1995;5:467-74.
44. Wewer UM, Durkin ME, Zhang X, et al. Laminin (32 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995;45:2099-101.
45. Xu H, Christmas P, Wu X-R, et al. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sei USA 1994;91:5572-6.
46. Madrid RE, Jaros E, Cullen MJ, Bradley WG. Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 1975;257:319-21.